These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6096150)

  • 21. Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis.
    Roberton DM; Hosking CS
    Aust Paediatr J; 1983 Sep; 19(3):178-81. PubMed ID: 6316890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
    Fanconi S; Seger R; Joller P; Issler C; Schär G
    Eur J Pediatr; 1982 Nov; 139(3):176-80. PubMed ID: 6297913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of transfer factor on neutrophil function in chronic mucocutaneous candidiasis.
    Lawton JW; Costello C; Barclay GR; Urbaniak SJ; Darg C; Raeburn JA; Uttley WS; Kay AB
    Br J Haematol; 1976 May; 33(1):137-42. PubMed ID: 1083741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A successful treatment of chronic mucocutaneous candidiasis by interleukin-2].
    Kondo M; Nakagawa K; Toyoda T; Tsuji H; Murakami S; Oku N; Itoh K; Shimazaki C; Nakagawa M; Fujita N
    Nihon Naika Gakkai Zasshi; 1989 Nov; 78(11):1609-10. PubMed ID: 2614208
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole.
    Morrison JG; Anderson R
    S Afr Med J; 1981 Feb; 59(7):237-9. PubMed ID: 6256921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of ketoconazole on cellular and humoral immune functions.
    van Rensburg CE; Anderson R; Jooné G; van der Merwe MF; Eftychis HA
    J Antimicrob Chemother; 1983 Jan; 11(1):49-55. PubMed ID: 6298175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness.
    Fischer A; Pichat L; Audinot M; Griscelli C
    Clin Exp Immunol; 1982 Mar; 47(3):653-60. PubMed ID: 6211308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
    Horsburgh CR; Kirkpatrick CH
    Am J Med; 1983 Jan; 74(1B):23-9. PubMed ID: 6295149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic mucocutaneous candidiasis. A case report].
    Montero Mora P; Domínguez Calderón F; Vigna García A
    Rev Alerg Mex (1987); 1990; 37(1):29-31. PubMed ID: 2367805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immune system function in candidiasis patients].
    Karaev ZO; Sardyko NV; Lebedeva TN; Pokrovskaia OL; Golikova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):63-8. PubMed ID: 3324585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole.
    Kennedy CT; Valdimarsson H; Hay RJ
    J R Soc Med; 1981 Feb; 74(2):158-62. PubMed ID: 6259351
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic mucocutaneous candidiasis.
    Kirkpatrick CH
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S14-7. PubMed ID: 8077500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy in cancer treatment. A comparative study with chronic muco-cutaneous candidiasis.
    Higgs JM
    Clin Oncol; 1980 Jun; 6(2):95-112. PubMed ID: 6967793
    [No Abstract]   [Full Text] [Related]  

  • 34. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Montagnani A; Negosanti M; Patrizi A
    Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic mucocutaneous candidiasis revisited.
    Palma-Carlos AG; Palma-Carlos ML
    Allerg Immunol (Paris); 2001 Jun; 33(6):229-32. PubMed ID: 11505806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Familial chronic mucocutaneous candidiasis. Study of 2 families].
    García-Pérez A; Gómez de la Concha E; Guerra Rodríguez P
    Med Cutan Ibero Lat Am; 1984; 12(1):33-40. PubMed ID: 6330471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer factor treatment of chronic mucocutaneous candidiasis: requirement for donor reactivity to candida antigen.
    Littman BH; Rocklin RE; Parkman R; David JR
    Clin Immunol Immunopathol; 1978 Jan; 9(1):97-110. PubMed ID: 618414
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic mucocutaneous candidiasis treated with transfer factor.
    Sousa MD; Cochran R; Mackie R; Parratt D; Arala-Chaves M
    Br J Dermatol; 1976 Jan; 94(1):79-83. PubMed ID: 1252343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with ketoconazole in diabetic patients with vaginal candidiasis.
    Balbi C; D'Ajello M; Balbi GC
    Drugs Exp Clin Res; 1986; 12(5):413-4. PubMed ID: 3720526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.